Medical Developments International (MDI)
Sabrina Pieris has a diverse background in the pharmaceutical industry, with experience in business support, brand management, and office administration. Currently working at Medical Developments International as the Business Support Manager and Global Respiratory Sales and Product Specialist, Sabrina previously held positions at Aspen Pharma, Sigma Pharmaceuticals, and Orphan Australia. Sabrina obtained their degree from the University of Tasmania in the Medicines Australia Continuing Education Program.
Medical Developments International (MDI)
"Delivering emergency medical solutions dedicated to improving patient outcomes" Medical Developments International (MDI) is one of Australia’s leading specialised healthcare companies. With an industry leading range of products in the areas of pain management, asthma and resuscitation, plus veterinary equipment, MDI has supplied healthcare professionals and patients innovative solutions since 1971. MDI is a publicly listed company on the Australian Stock Exchange (ASX) with both its head office and state of the art manufacturing facilities located in Victoria, Australia. MDI manufacture the innovative pain relief product, Penthrox® that has been widely adopted by organisations throughout Australia. MDI has a proud history in human and veterinary medicine, throughout Australia as well as internationally. For over 30 years MDI's key products have helped healthcare professionals achieve better health outcomes for their patients MDI is compliant with Good Manufacturing Practices as well as ISO 13485 for the manufacture of several of its products (including both pharmaceutical and medical products). Several MDI products are also CE marked, enabling them to be sold into the European Community.